26-Mar-2012
Professor Rury Holman gave a keynote talk at the Second Annual PharmaCoEconomics Middle East Forum in Abu Dhabi on 23rd March.
His talk described how the UKPDS model can quantify the burden of type 2 diabetes by simulating and predicting its many complications, with their different impacts on quality of life and different cost consequences, over a lifetime.
Professor Holman also showed how the model can be used by healthcare decision makers to estimate which treatment strategies would be most beneficial for patients with different diabetic complications.
International and regional experts, regulators, and other key stakeholders attended the symposium - the only event where all key regulators in the Middle East region meet under the same roof to discuss the challenges we face together in health economics spending.